Dfine For Doctors
Features
Key Attributes
Designed with precision in sight
Energy distribution chart
Aurovue Dfine provides less dependence on spectacles by providing 37% energy to near vision, which is higher than other imported MFIOL, and 45% energy to the distance vision that provide patients uncompromised near and distance visions in their daily life.
Clinical trial
Aurovue Dfine lens was implanted in 138 patients bilaterally with a follow up after a year from the implant. The results showed that 93% of the patients had 6/6p or better UCBDVA and 98% of the patients exhibited N6 UCBNVA.
Apodized and tropical conditions
First Indian Apodized diffractive MFIOL for optimum energy distribution across all ranges of vision in varying light conditions. This optimisation has been done specially for tropical conditions, to ensure the best results for patients even after a few years after the procedure.
Angle kappa machine
Exclusive angle kappa measuring device designed to help surgeons recommend Aurovue Dfine MFIOL to patients with confidence.
VD tool software.
First and only validated software tool to objectively assess postoperative visual disturbances, if any, experienced by the patients.
Additional support
Aurolab will provide support in terms of lifestyle questionnaire, counselling tools and on call clinical optometrist assistance.
Email: dfine@aurolab.com
Call: +91 9442561925